Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 2 Clinical outcomes of both groups
Variable | TXA group (n = 39) n (%) or mean ± SD (range) | Control group (n = 31) n (%) or mean ± SD (range) | 95% CI (lower to upper) | p-Value | |
|---|---|---|---|---|---|
TXA group | Control group | ||||
Operative time (min) | 57.4 ± 12.8 (43–109) | 60.4 ± 11.7 (42–89) | 53.4–61.4 | 56.3–64.5 | 0.315† |
Intraoperative blood loss (mL) | 106.5 ± 36.1 (78–200) | 122.0 ± 32.6 (75–207) | 95.5–117.5 | 111.0–133.0 | 0.067† |
Hidden blood loss (mL) | 630.5 ± 98.6 (409–807) | 893.4 ± 140.3 (644–1175) | 599.5–661.5 | 844.4–942.4 | < 0.001† |
Total blood loss (mL) | 736.9 ± 102.2 (567–927) | 1015.4 ± 152.4 (773–1285) | 704.9–768.9 | 961.4–1069.4 | < 0.001† |
HBpost-1* (g/L) | 108.9 ± 14.9 (85–140) | 99.2 ± 13.8 (80–132) | 104.2–113.6 | 94.3–104.1 | 0.007† |
HBpost-3* (g/L) | 87.4 ± 16.3 (63–128) | 79.8 ± 10.9 (56–110) | 82.3–92.5 | 76.0–83.6 | 0.029† |
Postoperative HB drop (g/L) | 46.8 ± 10.8 (22–80) | 55.0 ± 13.7 (31–79) | 43.4–50.2 | 50.2–59.8 | 0.007† |
Transfusion rate (%) | 2.6% (1/39) | 12.9% (4/31) | 0.279†† | ||
Postoperative LHS (day) | 4.3 ± 0.8 (3–6) | 4.6 ± 0.8(3–6) | 4.1–4.6 | 4.3–4.9 | 0.124† |
DVT (%) | 2.6% (1/39) | 3.2% (1/31) | 1.000†† | ||
Harris hip score (point) | 91.8 ± 4.9 (80–100) | 91.1 ± 6.1 (83–100) | 90.3–93.3 | 89.0–93.2 | 0.596† |